Gastrointestinal Unit 2, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi of Milan, Milan, Italy.
Clin Gastroenterol Hepatol. 2013 Jul;11(7):784-9. doi: 10.1016/j.cgh.2012.12.041. Epub 2013 Jan 30.
BACKGROUND & AIMS: Many patients with gastroesophageal reflux disease (GERD) have persistent reflux despite treatment with proton pump inhibitors (PPIs). Mixed gas-liquid reflux events are more likely to be perceived as symptomatic. We used esophageal impedance monitoring to investigate whether esophageal gas is processed differently among patients with GERD who do and do not respond to PPI therapy.
We performed a prospective study of 44 patients with typical reflux symptoms with high levels of esophageal acid exposure during a 24-hour period; 18 patients were fully responsive, and 26 did not respond to PPI therapy. Twenty-four-hour pH impedance recordings were analyzed for fasting and prandial air swallows and reflux characteristics, including the presence of gas in the refluxate.
PPI-refractory patients had a higher number (83.1 ± 12.7 vs 47.8 ± 7.3, P < .05) and rate (10.5 ± 1.4 vs 5.9 ± 0.8/10 minutes, P < .05) of prandial air swallows than patients who responded to PPI therapy; they also had a higher number (25.5 ± 4.0 vs 16.8 ± 3.3, P < .05) and proportion (70% ± 0.03% vs 54% ± 0.06%, P < .05) of postprandial, mixed gas-liquid reflux. Symptoms of PPI-refractory patients were more often preceded by mixed gas-liquid reflux events than those of PPI responders. Fasting air swallowing and other reflux characteristics did not differ between patients who did and did not respond to PPIs.
Some patients with GERD who do not respond to PPI therapy swallow more air at mealtime than those who respond to PPIs and also have more reflux episodes that contain gas. These factors, combined with mucosal sensitization by previous exposure to acid, could affect perception of symptoms. These patients, who can be identified on standard 24-hour pH impedance monitoring, might be given behavioral therapy to reduce mealtime air swallowing.
许多胃食管反流病(GERD)患者尽管接受质子泵抑制剂(PPIs)治疗,但仍存在持续性反流。混合性气液反流事件更有可能被感知为有症状。我们使用食管阻抗监测来研究在对 PPI 治疗有反应和无反应的 GERD 患者中,食管气体是否存在不同的处理方式。
我们对 44 例具有典型反流症状且 24 小时食管酸暴露水平较高的患者进行了前瞻性研究;18 例患者完全有反应,26 例对 PPI 治疗无反应。分析 24 小时 pH 阻抗记录,以评估空腹和进食时的空气吞咽以及反流特征,包括反流物中是否存在气体。
PPI 难治性患者的进食时空气吞咽次数(83.1 ± 12.7 比 47.8 ± 7.3,P <.05)和频率(10.5 ± 1.4 比 5.9 ± 0.8/10 分钟,P <.05)均高于对 PPI 治疗有反应的患者;他们还经历了更多的餐后混合性气液反流次数(25.5 ± 4.0 比 16.8 ± 3.3,P <.05)和比例(70% ± 0.03% 比 54% ± 0.06%,P <.05)。PPI 难治性患者的症状更多地由混合性气液反流事件引起,而不是 PPI 应答者。空腹空气吞咽和其他反流特征在对 PPI 有反应和无反应的患者之间没有差异。
一些对 PPI 治疗无反应的 GERD 患者在进餐时比对 PPI 有反应的患者吞咽更多的空气,并且也有更多含有气体的反流事件。这些因素,加上先前暴露于酸引起的黏膜敏化,可能会影响症状的感知。这些可以通过标准的 24 小时 pH 阻抗监测来识别的患者,可能会接受行为治疗以减少进餐时的空气吞咽。